New drug HS-20136-2 enters first human safety trial
NCT ID NCT07483437
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug, HS-20136-2, in 38 healthy adults to see if it is safe and how the body handles it. Participants receive a single injection of either the drug or a placebo, and researchers monitor for side effects and measure drug levels in the blood. Since this is a Phase 1 trial, it focuses on safety and dosing, not on treating any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HS-20136-2 injection
What could go wrong
This is a very early Phase 1 study in only 38 healthy people, so it cannot prove the drug works for any disease. The main goal is just safety, not treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain Metabolism Study Using PET/fMRI (NCT05756335)
- Short-term arm immobilization & muscle metabolis NCT06750497
- Parent-led app boosts kids' motor & brain skills NCT07680075
- DigiKids App-Based Motor Skills Trial for Kids (NCT07679633)
- QX-4533 Safety Study in Healthy People | NCT07678463
- Pomegranate Supplement & Gut Health in Alcohol L NCT07678567
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, 5000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••